Baricitinib-Loaded EVs Promote Alopecia Areata Mouse Hair Regrowth by Reducing JAK-STAT-Mediated Inflammation and Promoting Hair Follicle Regeneration

    December 2024 in “ Drug Discoveries & Therapeutics ”
    Haowen Tang, Fangfang Wang, Jing Wang, Ziqi Zhao, Ying Zhang, Yang Li, Bingmin Li
    From the encyclopedia
    Baricitinib →

    JAK inhibitor that reduces inflammation and immune attacks on hair follicles, leading to potential hair regrowth, especially in alopecia areata cases

    Alopecia Areata →

    autoimmune disorder causing patchy hair loss

    Image
    Studysummary This study investigated using baricitinib-loaded mesenchymal stem cell exosomes injected locally in an alopecia areata mouse model and found that this method improved hair regrowth better than baricitinib or exosomes alone, potentially offering a new therapeutic approach for treating alopecia areata.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    This study explores the use of baricitinib-loaded mesenchymal stem cell exosomes (EVs) for treating alopecia areata (AA) in a mouse model. Traditional oral administration of baricitinib, while effective, has significant side effects and poor long-term efficacy. The study found that local injection of baricitinib-loaded EVs (EV-B) significantly improved hair regrowth compared to control groups, with the EV-B group showing the best results. The enhanced effectiveness is attributed to improved drug delivery and the synergistic effects of EVs, which better inhibit the JAK-STAT pathway and upregulate the Wnt/β-catenin pathway. These findings suggest that EV-B could be a promising new therapeutic approach for AA.
    Discuss this study in the Community →